Gravity Determines Cell Size

Researchers show that cells may have evolved to be small because of gravitational forces.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Human oocyteWIKIMEDIA, EKEMIt has long been believed that cells with diameters much bigger than 10 microns—the typical size of most eukaryotic cells—are rare because it is difficult for larger cells to acquire nutrients or expel waste. The oocytes of most animals are much bigger, and they likewise have larger nuclei, which often contain high concentrations of the protein actin. Cell biologists Marina Feric and Clifford Brangwynne of Princeton University in New Jersey have shown that cells are likely small because of gravitational forces and that the extra actin in oocyte nuclei stabilizes the responses of larger cells to gravity. Their work, published in the October issue of Nature Cell Biology, was surprising because cell biologists “really have never, in my experience, worried about gravity—or thought about it,” Brangwynne told The Atlantic.

Brangwynne and Feric injected tiny plastic beads into the germinal vesicles—nuclei—of 1 millimeter oocytes from African clawed frogs (Xenopus laevis). Beads of different radii moved differently within the nuclei—larger particles got stuck more often than smaller ones—which suggested that they were traveling through a network of actin. When the researchers treated the eggs with drugs that disrupt actin or injected them with a factor that decreased actin concentration in the nuclei, plastic beads of all sizes moved similarly. When they disrupted actin and injected metallic beads, these beads and endogenous organelles eventually settled to the bottom of the nucleus. Brangwynne and Feric applied forces to the germinal vesicles and showed that actin polymerized in response. “Gravity becomes really important at a smaller scale than you ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies